Transforming healthcare risk financing.

Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid precision infectious disease discovery. Our software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.

Debut is pioneering the beauty industry’s shift from traditionally sourced ingredients derived from petroleum and cultivation to high-performing and inherently sustainable biotech ingredients. As a fully vertically-integrated global company, Debut creates superior, scientifically-engineered, bio-based, and clinically-proven products and brands at scale to benefit people and planet. Our mission is to create a new beauty standard based on potency, purity, and performance.

Ellipsis Health was founded with the belief that a person’s mental health should have the same priority as one’s physical health. The company saw an opportunity to connect the dots between the two - giving voice to a new standard of mental health care. By harnessing the unique power of the human voice as a biomarker for mental well-being, along with machine learning and AI, Ellipsis Health has established the first vital sign for mental health. Its technology identifies, measures, and monitors the severity of depression and anxiety at scale by analyzing a short sample of natural speech to create an objective and scalable clinical decision-support tool. Through partnerships with providers, payers, employers, and digital health companies, Ellipsis Health is working to positively impact the quality of care, shorten the time to diagnosis, drive workflow efficiencies, reduce costs, and improve patient outcomes.

Great Expectations has created an end-to-end solution for your data quality process and a unique Expectation-based approach to testing, backed by the world’s most popular data quality framework.

Helm takes the confusion out of health insurance by making every service easily shoppable, upfront. Guaranteed.

IgniteData’s Archer technology is transforming the way hospitals and research sites transfer data for clinical trials. EHR-to-EDC data transfer provides fast, accurate patient data for clinical studies, significantly reducing the requirement for laborious data transcription and Source Data Verification (SDV).

Inito is on a mission to simplify healthcare and wellness with the most advanced health trackers. Our devices are engineered to help you take complete control of your well-being by accessing real-time data and values at your fingertips. Inito has recorded 8x growth in 2022, is projected to grow over 4x in 2023, and launch in 10+ countries through 2024. The Inito fertility monitor is the only hormone tracking device that accurately measures all four fertility hormones. It is trusted by over 20,000+ couples in India and the US. Inito is backed by the best investors in the world – Y Combinator and many others in the US, Singapore, and India.

FlyteHealth is a tech-enabled healthcare services organization born of the belief that everyone deserves to live a healthy life. Our efforts to bring the most effective health care to people with obesity, while making it cost-efficient to do so, mean that more people can transform their health for the better—now and for the rest of their lives. We were founded by physicians who were the first to recognize obesity not as a simple issue of willpower, but as a complex disease that requires expert medical treatment. Based on their decades of research and caring for patients, our clinically proven approach combines the latest in personalized medication therapy and behavior coaching that not only helps people lose weight for the long term, but significantly improves related conditions. Our obesity treatment platform, powered by Flyte Intelligence, is built from the largest data set of obesity and chronic disease research available, empowering healthcare providers—our own FlyteHealth clinicians.

Every single machine learning (ML)-driven breakthrough, from language translation to GO championships, was immediately preceded not by an algorithmic innovation but by a massive, well-controlled, purpose-built dataset. An ML-driven breakthrough in medicinal chemistry is going to require a similar dataset, but such high-quality, well-structured experimental data doesn’t exist yet. We're building that dataset by making physical measurements of lots of targets (with automated in-house protein production) screened against lots of compounds (with DNA-encoded chemical libraries). We're also building the ML models that will eventually be generalizable across any protein and novel medicines using insights from our models.

We engage underserved behavioral health and substance use patients with chat-based peer support groups and use AI to scale the efforts of existing clinicians. Our platform is currently live at select sites. We're hiring: https://jobs.lever.co/marigoldhealth/

The family's healthcare home.